SNSE

Conviction 42HealthcareScan · Fri, Jun 26, 2026

SNSE$13.85+6.54%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 66.42K

Mar 17Apr 2Apr 22May 8May 28Jun 15

Sensei Biotherapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.senseibio.com ↗

Price13.85

Change+6.54%

Gap+17.00%

Rel volume4.67×

Avg volume55.97K

Avg $ vol866.23K

SMA 2015.96

SMA 5023.03

SMA 20016.24

Price vs 50-39.87%

Price vs 200-14.73%

MA stackmixed

50/200 cross—

Supertrenddown · 19.72

RSI (14)39

MACD hist-0.03

MACD crossbear · 5d

Stoch %K / %D29 / 16

ADX (14)27

+DI / −DI18 / 24

RSI divergence—

MACD divergence—

ATR %+19.44%

ADR %16.26%

52w high35.07

52w low0.0000

From 52w high-60.51%

Above 52w low—

New 52w highNo

SqueezeOff

Bollinger width69.19%

%B0.31

Donchian pos26.22%

Donchian high22.49

Donchian low10.78

AVWAP (52w high)27.17

vs AVWAP high-49.02%

AVWAP (52w low)22.60

vs AVWAP low-38.70%

OBV trendFlat

Chaikin MF (20)-0.42

Today vs 20d4.67×

Avg vol (14d)66.42K

Avg vol (20d)55.97K

Avg $ vol (20d)866.23K

Market cap—

RS 3m (vs SPY)-66.50%

RS 6m (vs SPY)+44.36%

RS line new highNo

Trend template3/8

Technical rank39.9

1 week+6.54%

1 month-30.12%

3 months-53.68%

6 months+53.89%

1 year+4028.17%

YTD+43.60%

P/E-0.88

P/B-0.14

P/S—

P/FCF-0.91

EPS-16.72

Div yield—

ROE15.36%

ROA-10.27%

Debt/Eq-0.00

Current14.39

EV/EBITDA6.01

Gross margin—

Net margin—

Rev growth—

EPS growth30.08%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-133.17M

Revenue—

Net income-170.24M

Gross profit—

Free cash flow-20.47M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out1.34M

Employees29

ListedThu, Feb 4, 2021

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction42 / 100

Pattern quality—

Tech rank39.9 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance33.11

Support13.13

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SNSE

All disclosures →

No recent disclosed trades by Congress in SNSE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SNSE · 2 buys · 8 sells

Insider	Side	Shares	Value	Traded	Filed
Peyer James 10% owner · Common Stock · 2026-06-01	Sell	476	$10K	2026-06-01	2026-06-01
Cambrian BioPharma Inc 10% owner · Common Stock · 2026-06-01	Sell	24.52K	$490K	2026-06-01	2026-06-01
Cambrian BioPharma Inc 10% owner · Common Stock · 2026-06-01	Sell	476	$10K	2026-06-01	2026-06-01
Peyer James 10% owner · Common Stock · 2026-06-01	Sell	24.52K	$490K	2026-06-01	2026-06-01
MILLENNIUM GROUP MANAGEMENT LLC 10% owner · Common Stock · 2026-04-07	Buy	1.11K	$37K	2026-04-07	2026-05-15
ICS OPPORTUNITIES II LLC 10% owner · Common Stock · 2026-04-07	Buy	1.11K	$37K	2026-04-07	2026-05-15
ICS OPPORTUNITIES II LLC 10% owner · Common Stock · 2026-04-07	Sell	2.12K	$61K	2026-04-07	2026-05-15
ENGLANDER ISRAEL A 10% owner · Common Stock · 2026-04-07	Sell	300	$10K	2026-04-07	2026-05-15
ICS OPPORTUNITIES II LLC 10% owner · Common Stock · 2026-04-07	Sell	4.42K	$139K	2026-04-07	2026-05-15
MILLENNIUM MANAGEMENT LLC 10% owner · Common Stock · 2026-04-07	Sell	2.12K	$61K	2026-04-07	2026-05-15

SEC filings

EDGAR filings in SNSE · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.